James R. Baker

James R. Baker

Auto-generated profile, based on publicly available information

James R. Baker

Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan Medical School, Ann Arbor, USA

Research Focus & Metrics

Academic Career Length

70Years (1957-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
AQAntonio Quintana
Antonio Quintana
EREwa Raczka
Ewa Raczka
LPLars Piehler
Lars Piehler
ILInhan Lee
Inhan Lee
AMAndrzej Myc
Andrzej Myc
JBJames R. Baker
James R. Baker
Purpose. We sought to develop nanoscale drug delivery materials that would allow targeted intracellular delivery while having an imaging capability for tracking uptake of the material. A complex...

22 June 2007 in Small
Verified
Journal Article
Closed access
PDF file
Xiangyang ShiXiangyang Shi
Xiangyang Shi
SWSuhe Wang
Suhe Wang
SMSasha Meshinchi
Sasha Meshinchi
MAMary E. Van Antwerp
Mary E. Van Antwerp
XBXiangdong Bi
Xiangdong Bi
JBJames R. Baker
James R. Baker

5 May 2008 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
Xiangyang ShiXiangyang Shi
Xiangyang Shi
SWSuhe Wang
Suhe Wang
SSScott D. Swanson
Scott D. Swanson
SGSong Ge
Song Ge
ZCZhengyi Cao
Zhengyi Cao
JBJames R. Baker
James R. Baker

1 September 2000 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
THT. Hamouda
T. Hamouda
JBJ.R. Baker
J.R. Baker

26 May 2011 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
TTThommey P. Thomas
Thommey P. Thomas
SGSascha N. Goonewardena
Sascha N. Goonewardena
IMIstvan J. Majoros
Istvan J. Majoros
AKAlina Kotlyar
Alina Kotlyar
ZCZhengyi Cao
Zhengyi Cao
JBJames R. Baker
James R. Baker
Objective: To investigate the uptake of a poly(amidoamine) dendrimer (generation 5 [G5]) nanoparticle covalently conjugated to polyvalent folic acid (FA) as the targeting ligand into macrophages, and to investigate the activity of an FA‐ and methotrexate (MTX)–conjugated dendrimer (G5‐FA‐MTX) as a therapeutic for the inflammatory disease of arthritis.Methods: In vitro studies were performed in macrophage cell lines and in isolated mouse macrophages to check the cellular uptake of fluorescence‐tagged G5‐FA nanoparticles, using flow cytometry and confocal microscopy. In vivo studies were conducted in a rat model of collagen‐induced arthritis to evaluate the therapeutic potential of G5‐FA‐MTX.Results: Folate‐targeted dendrimer bound and internalized in a receptor‐specific manner into both folate receptor β–expressing macrophage cell lines and primary mouse macrophages. The conjugate G5‐FA‐MTX acted as a potent antiinflammatory agent and reduced arthritis‐induced parameters of inflammation such as ankle swelling, paw volume, cartilage damage, bone resorption, and body weight decrease.Conclusion: The use of folate‐targeted nanoparticles to specifically target MTX into macrophages may provide an effective clinical approach for antiinflammatory therapy in rheumatoid arthritis.

31 August 2007 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
SWSuhe Wang
Suhe Wang
Xiangyang ShiXiangyang Shi
Xiangyang Shi
MAM. Van Antwerp
M. Van Antwerp
ZCZ. Cao
Z. Cao
SSS. D. Swanson
S. D. Swanson
JBJ. R. Baker
J. R. Baker